INFLUENZA VACCINE COMPOSITION FOR USE IN IMMUNO-COMPROMISED POPULATIONS

摘要

The invention relates to a composition for use as an intranasally administered vaccine comprising one or more non-live influenza virus antigens, and an adjuvant comprising: one or more carboxylic acids, an aqueous medium, and optionally one or more mono-glycerides.